Shock Wave Therapy for Lateral Hip Pain, Caused by Tendon Pathology

Focused Extracorporeal Shock Wave Therapy for Greater Trochanteric Pain Syndrome With Gluteal Tendinopathy: a Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03142971

Enrollment

Registered

2017-05-08

Start date

2013-03-31

Completion date

2016-05-04

Last updated

2017-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinopathy

Keywords

Shock waves, Greater trochanteric pain syndrome

Brief summary

The aim of this randomized controlled study is to investigate if focal shock wave is an effective treatment, with respect to hip pain and lower limb function, in a population affected by greater trochanteric pain syndrome with gluteal tendinopathy.

Interventions

PROCEDUREfocused shock wave therapy

PROCEDUREultrasound therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* duration of lateral hip pain of six weeks or longer, * normal passive hip range of movement (ROM), * sonographic evidence of gluteal tendinopathy at their insertional site at the greater trochanter

Exclusion criteria

* general contraindication to extracorporeal shock wave therapy (pacemaker, pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area), * history of rheumatologic disease, * previous fractures or surgery in the affected limb, * full thickness tear of the gluteal tendons, * osteoarthritis of the hip (with ROM limitation), * clinical signs of lumbar radiculopathy, * corticosteroid injections or other conservative therapies (except pharmacological pain treatments) since the onset of the current pain episode.

Design outcomes

Primary

Measure	Time frame	Description
p-NRS	Baseline, at two months, at six months	Change from baseline p-NRS (pain-on-movement numeric rating scale) at 2 months and at 6 months.
LEFS score	Baseline, at two months, at six months	Change from baseline LEFS (Lower extremity functional scale) total score at 2 months and at 6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026